EFDID: 326876EFD: View Filing

Issuer: Applied Therapeutics Inc. (0001697532) - D

Accession: 0000950172-19-000131 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    Applied Therapeutics Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2016)
  • Address:
    545 5th Avenue, Suite 1400
    New York, NY 10173
  • Persons:
    Related Persons 8
    Shoshana Shendelman
    Executive Officer, Director 
    President, CEO and Chair of the Board of Directors
    Riccardo Perfetti
    Executive Officer 
    Chief Medical Officer
    Mark Vignola
    Executive Officer 
    Chief Financial Officer
    Les Funtleyder
    Director
    Stacy J. Kanter
    Director
    Teena Lerner
    Director
    Joel S. Marcus
    Director
    Jay S. Skyler
    Director
EDGAR: Offering Information
  • Accession Date:
    11/21/2019
  • First Sale Date:
    11/07/2019
  • Offering Amount:
    $20,014,988
  • Amount Sold:
    $20,014,988
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

Notices found in EFD

Filed:CA, TX, VA
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
John Dexter Pearson 6093501 Collage Partners, a division of CIM Securities LLC 120852 CA, IL, NY, TX, VA
N/A None Cowen and Company, LLC 7616 CA, IL, MA, NY, VA
N/A None UBS Securities LLC 7654 CA, IL, MA, NY, VA
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Applied Therapeutics Inc./s/ Mark VignolaMark VignolaChief Financial Officer2019-11-21